About Cysteine and histidine-rich domain-containing protein 1
Cysteine and histidine-rich domain-containing protein 1 (CHORDC1) is a protein
from Homo sapiens identified by UniProt accession
Q9UHD1, 332 residues long.
MolForge cross-references it against 0 known binders and
205 disease associations.
Target properties
| Protein name | Cysteine and histidine-rich domain-containing protein 1 |
| UniProt accession | Q9UHD1 |
| Gene | CHORDC1 |
| Organism | Homo sapiens |
| Length | 332 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (205)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.53
- body mass index · score 0.44
- basophil percentage of leukocytes · score 0.34
- mathematical ability · score 0.33
- self reported educational attainment · score 0.30
- uric acid measurement · score 0.28
- visceral adipose tissue measurement · score 0.25
- unipolar depression · score 0.24
- body height · score 0.23
- basophil count · score 0.21
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9UHD1-F1 | alphafold | PREDICTED | 81.74 | — |
Amino-acid sequence (332 residues)
MALLCYNRGC GQRFDPETNS DDACTYHPGV PVFHDALKGW SCCKRRTTDF SDFLSIVGCT KGRHNSEKPP EPVKPEVKTT EKKELCELKP KFQEHIIQAP KPVEAIKRPS PDEPMTNLEL KISASLKQAL DKLKLSSGNE ENKKEEDNDE IKIGTSCKNG GCSKTYQGLE SLEEVCVYHS GVPIFHEGMK YWSCCRRKTS DFNTFLAQEG CTKGKHMWTK KDAGKKVVPC RHDWHQTGGE VTISVYAKNS LPELSRVEAN STLLNVHIVF EGEKEFDQNV KLWGVIDVKR SYVTMTATKI EITMRKAEPM QWASLELPAA KKQEKQKDAT TD
Explore Cysteine and histidine-rich domain-containing protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets